Home > Publications Database > Dataset: Quantitative proteomics of CSF from the Alzheimer's disease mouse model 5xFAD > print |
001 | 279479 | ||
005 | 20250710100950.0 | ||
037 | _ | _ | |a DZNE-2025-00806 |
100 | 1 | _ | |a Müller, Stephan A |0 P:(DE-2719)2810938 |b 0 |u dzne |
245 | _ | _ | |a Dataset: Quantitative proteomics of CSF from the Alzheimer's disease mouse model 5xFAD |
260 | _ | _ | |c 2025 |b PRoteomics IDEntifications Database |
336 | 7 | _ | |a MISC |2 BibTeX |
336 | 7 | _ | |a Dataset |b dataset |m dataset |0 PUB:(DE-HGF)32 |s 1752049604_18284 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a Chart or Table |0 26 |2 EndNote |
336 | 7 | _ | |a Dataset |2 DataCite |
336 | 7 | _ | |a DATA_SET |2 ORCID |
336 | 7 | _ | |a ResearchData |2 DINI |
520 | _ | _ | |a The 5xFAD mouse model was used to study the influence of amyloid pathology on the cerebrospinal fluid (CSF) proteome. Therefore, CSF of 7-months old 5xFAD and WT control mice was sampled with an improved collection protocol. Using a minute amount of 5 µL CSF, we applied data dependent and data independent acquisition of the same samples on a Q-Exactive HF mass spectrometer. Comparison of DDA and DIA demonstrate a higher data completeness for DIA. The results show a strong effect on microglia activation exemplified by strongly increased abundances of Trem2 and Cst7. Furthermore, neurodegenerative markers such as neurofilaments and tau (Mapt) were strongly increased for 5xFAD mice. |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
700 | 1 | _ | |a Lichtenthaler, Stefan |0 P:(DE-2719)2181459 |b 1 |u dzne |
787 | 0 | _ | |a Lourbopoulos, Athanasios et.al. |d Bethesda, Md. : The American Society for Biochemistry and Molecular Biology, 2025 |i RelatedTo |0 DZNE-2025-00672 |r |t An Improved Method for Sampling and Quantitative Protein Analytics of Cerebrospinal Fluid of Individual Mice. |
856 | 4 | _ | |u https://wwwdev.ebi.ac.uk/pride/archive/projects/PXD053568 |
909 | C | O | |o oai:pub.dzne.de:279479 |p VDB |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2810938 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2181459 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
914 | 1 | _ | |y 2025 |
920 | 1 | _ | |0 I:(DE-2719)1110006 |k AG Lichtenthaler |l Neuroproteomics |x 0 |
980 | _ | _ | |a dataset |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1110006 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|